These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 16186470

  • 1. Ability of physicians to diagnose and manage illness due to category A bioterrorism agents.
    Cosgrove SE, Perl TM, Song X, Sisson SD.
    Arch Intern Med; 2005 Sep 26; 165(17):2002-6. PubMed ID: 16186470
    [Abstract] [Full Text] [Related]

  • 2. Recognition and management of bioterrorism infections.
    O'Brien KK, Higdon ML, Halverson JJ.
    Am Fam Physician; 2003 May 01; 67(9):1927-34. PubMed ID: 12751654
    [Abstract] [Full Text] [Related]

  • 3. Histopathology and immunohistochemistry in the diagnosis of bioterrorism agents.
    Guarner J, Zaki SR.
    J Histochem Cytochem; 2006 Jan 01; 54(1):3-11. PubMed ID: 16148309
    [Abstract] [Full Text] [Related]

  • 4. Clinical management of potential bioterrorism-related conditions.
    Adalja AA, Toner E, Inglesby TV.
    N Engl J Med; 2015 Mar 05; 372(10):954-62. PubMed ID: 25738671
    [Abstract] [Full Text] [Related]

  • 5. Threats in bioterrorism. I: CDC category A agents.
    Darling RG, Catlett CL, Huebner KD, Jarrett DG.
    Emerg Med Clin North Am; 2002 May 05; 20(2):273-309. PubMed ID: 12120480
    [Abstract] [Full Text] [Related]

  • 6. Physicians' understanding of the regulation of dietary supplements.
    Ashar BH, Rice TN, Sisson SD.
    Arch Intern Med; 2007 May 14; 167(9):966-9. PubMed ID: 17502539
    [Abstract] [Full Text] [Related]

  • 7. Bioterrorism's invisible threats: heightened awareness will help nurses identify real and suspected bioterrorism.
    Altman GB.
    Nurs Manage; 2002 Jan 14; 33(1):43, 45-7. PubMed ID: 11984331
    [Abstract] [Full Text] [Related]

  • 8. Bioterriorism: from threat to reality.
    Atlas RM.
    Annu Rev Microbiol; 2002 Jan 14; 56():167-85. PubMed ID: 12142472
    [Abstract] [Full Text] [Related]

  • 9. Bioterrorism: class A agents and their potential presentations in immunocompromised patients.
    Richard JL, Grimes DE.
    Clin J Oncol Nurs; 2008 Apr 14; 12(2):295-302. PubMed ID: 18390465
    [Abstract] [Full Text] [Related]

  • 10. Molecular diagnostic techniques for use in response to bioterrorism.
    Firmani MA, Broussard LA.
    Expert Rev Mol Diagn; 2003 Sep 14; 3(5):605-16. PubMed ID: 14510181
    [Abstract] [Full Text] [Related]

  • 11. Recognition of illness associated with the intentional release of a biologic agent.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2001 Oct 19; 50(41):893-7. PubMed ID: 11686473
    [Abstract] [Full Text] [Related]

  • 12. Management of patients exposed to biologic weapons.
    Yetman RJ, Parks D, Taft E.
    J Pediatr Health Care; 2002 Oct 19; 16(5):256-61. PubMed ID: 12226595
    [No Abstract] [Full Text] [Related]

  • 13. Evaluation of an online bioterrorism continuing medical education course.
    Casebeer L, Andolsek K, Abdolrasulnia M, Green J, Weissman N, Pryor E, Zheng S, Terndrup T.
    J Contin Educ Health Prof; 2006 Oct 19; 26(2):137-44. PubMed ID: 16802314
    [Abstract] [Full Text] [Related]

  • 14. Infectious agents of bioterrorism: a review for emergency physicians.
    Kman NE, Nelson RN.
    Emerg Med Clin North Am; 2008 May 19; 26(2):517-47, x-xi. PubMed ID: 18406986
    [Abstract] [Full Text] [Related]

  • 15. Biological and chemical terrorism: recognition and management.
    Noeller TP.
    Cleve Clin J Med; 2001 Dec 19; 68(12):1001-2, 1004-9, 1013-6. PubMed ID: 11765118
    [Abstract] [Full Text] [Related]

  • 16. [Bioterrorism and primary care].
    Mayer Pujadas MA, Alvarez Pasquín MJ, Gómez Marco J, Redondo Sánchez J, Muñoz Gutiérrez J, Cereceda Ferrés M, Batalla Martínez C, Comín Bertrán E, Pareja Bezares A, Piñeiro Guerrero R, Niño Martín V, Arranz Izquierdo J, Carceller P, Nodar Martín E, Ortega Martínez J, Vázquez Villegas J, Grupo de Prevención en Enfermedades Infecciosas. PAPPS-SemFYC, Grupo de Enfermedades Infecciosas. semFYC.
    Aten Primaria; 2002 Oct 15; 30(6):392-400. PubMed ID: 12396947
    [No Abstract] [Full Text] [Related]

  • 17. Diagnosis and management of suspected cases of bioterrorism: a pediatric perspective.
    Patt HA, Feigin RD.
    Pediatrics; 2002 Apr 15; 109(4):685-92. PubMed ID: 11927716
    [Abstract] [Full Text] [Related]

  • 18. Cutaneous manifestations of category A bioweapons.
    Aquino LL, Wu JJ.
    J Am Acad Dermatol; 2011 Dec 15; 65(6):1213.e1-1213.e15. PubMed ID: 21777993
    [Abstract] [Full Text] [Related]

  • 19. [Bioterrorism].
    Sata T.
    Nihon Hoigaku Zasshi; 2005 Oct 15; 59(2):119-25. PubMed ID: 16296383
    [Abstract] [Full Text] [Related]

  • 20. Bioterrorism.
    Bates N, Asgari-Jirhandeh N.
    Emerg Nurse; 2005 Oct 15; 9(8):21-5. PubMed ID: 11774753
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.